Cardiovascular Renal Metabolic

AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s

Erin A Bohula, Harriette Van Spall

Watch time: 2h 18m 6s (20 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
EASD 25: Prespecified Analysis of CONFIDENCE

Rajiv Agarwal

Watch time: 7m 31s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s
Semaglutide Modulates Key Pathways to Resolve MASH, Proteomic Analysis Reveals

Radcliffe CVRM

AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s

Jose Lopez, Tracy Makuvire, Jonathan D Davis, et al

Read time: 26m 29s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s

Andrew JS Coats, Stefan Anker

AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s

Erin A Bohula, Harriette Van Spall

Watch time: 2h 18m 6s (20 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
ESC Congress 2025 Releases its Late-Breaking Scientific Programme

ESC Congress 2025 Scientific Programme

Fausto J Pinto, John Spertus, , et al

Keith C Ferdinand

Gurushankar Govindarajan, James R Sowers, Craig S Stump

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Media

Erin A Bohula, Harriette Van Spall

Watch time: 2h 18m 6s (20 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists

Emily Lau

Watch time: 7m 24s
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice

Michelle O'Donoghue

Watch time: 5m 1s
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: The CORALreef HeFH Trial

Christie Ballantyne

Watch time: 5m 9s

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s
EASD 25: Prespecified Analysis of CONFIDENCE

Rajiv Agarwal

Watch time: 7m 31s

Yassir Javaid, ,

Watch time: 1h 7m 32s (4 videos)

Articles

Angiotensin-receptor Blocker Therapy—Chronic Kidney Disease and Diabetes

Domenic A Sica

,

Citation:

US Cardiology 2006;3(2):32–4

DOI:

https://doi.org/10.15420/usc.2006.3.2.32
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 11
  • Downloads: Downloads 0
  • Citations: 1

Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study

Sophia Zoungas

,

John Chalmers

,

Anushka Patel

,

Citation:

US Cardiology 2009;6(2):46–50

DOI:

https://doi.org/10.15420/usc.2009.6.2.46
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 87
  • Downloads: Downloads 1

Management of the Asymptomatic Diabetic Patient with Evidence of Ischemia

Dimitrios Bliagos

,

Ajay J Kirtane

,

Jeffrey W Moses

,

Citation:

US Cardiology 2010; 7(1):76–80

DOI:

https://doi.org/10.15420/usc.2010.7.1.76
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 65
  • Downloads: Downloads 3

Management of Cholesterol in Diabetes - A Review

Mohit Gupta

,

Borut Jug

,

Matthew J Budoff

,

Citation:

US Cardiology 2010;7(2):20–4

DOI:

https://doi.org/10.15420/usc.2010.7.2.20
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 380
  • Downloads: Downloads 12
  • Citations: 1